marbofloxacin has been researched along with Equine Diseases in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Andrés-Larrea, MIS; Bhardwaj, P; de la Fe, C; Dova, SW; Fernández-Varón, E; Litterio, NJ; Lorenzutti, AM; Rodríguez, CMC; Rubio-Langre, S; Serrano-Rodríguez, JM; Sidhu, PK | 1 |
Endo, Y; Hobo, S; Ishikawa, Y; Ishimaru, M; Korosue, K; Nakai, K; Omura, T; Tsuchiya, T | 1 |
Carretero, M; de Lucas, JJ; Forés, P; González, F; Nieto, J; Rodríguez, C; San Andrés, MD; San Andrés, MI; Waxman, S | 1 |
Bernard, S; Bousquet-Melou, A; Schneider, M; Toutain, PL | 1 |
Bousquet-Mélou, A; Concordet, D; Doucet, MY; Peyrou, M; Schneider, M; Vrins, A | 1 |
Ensink, JM; van Duijkeren, E; van Soest, JM; Voermans, M | 1 |
De Lucas, JJ; González, F; Nieto, J; Rodríguez, C; San Andrés, MD; San Andrés, MI; Serres, C; Waxman, S | 1 |
Art, T; Bedoret, D; de Moffarts, B; Lekeux, P; van Erck, E | 1 |
2 trial(s) available for marbofloxacin and Equine Diseases
Article | Year |
---|---|
Effects of pre-shipping marbofloxacin administration on fever and blood properties in healthy Thoroughbreds transported a long distance.
Topics: Animals; Anti-Bacterial Agents; Enrofloxacin; Female; Fever; Fluoroquinolones; Horse Diseases; Horses; Male; Transportation | 2015 |
Population pharmacokinetics of marbofloxacin in horses: preliminary analysis.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Enzyme Inhibitors; Female; Fluoroquinolones; Gastritis; Horse Diseases; Horses; Injections, Intramuscular; Male; Mastitis; Quinolones; Regression Analysis; Respiratory Tract Infections; Topoisomerase II Inhibitors | 2004 |
6 other study(ies) available for marbofloxacin and Equine Diseases
Article | Year |
---|---|
Population pharmacokinetics and pharmacokinetic/pharmacodynamic evaluation of marbofloxacin against Coagulase-negative staphylococci, Staphylococcus aureus and Mycoplasma agalactiae pathogens in goats.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Coagulase; Fluoroquinolones; Goat Diseases; Goats; Horse Diseases; Horses; Microbial Sensitivity Tests; Mycoplasma agalactiae; Sheep; Sheep Diseases; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration.
Topics: Absorption; Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Biological Availability; Chromatography, High Pressure Liquid; Colony Count, Microbial; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Horse Diseases; Horses; Injections, Intramuscular; Injections, Intravenous; Male; Metabolic Clearance Rate; Quinolones; Reference Values; Tissue Distribution; Treatment Outcome | 2002 |
Pharmacokinetics of marbofloxacin in horses.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Colony Count, Microbial; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Horse Diseases; Horses; Injections, Intravenous; Injections, Subcutaneous; Intestinal Absorption; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Nutritive Value; Quinolones; Random Allocation; Treatment Outcome | 2002 |
Clinical efficacy of intravenous administration of marbofloxacin in a Staphylococcus aureus infection in tissue cages in ponies.
Topics: Animals; Chromatography, High Pressure Liquid; Colony Count, Microbial; Diffusion Chambers, Culture; Enzyme Inhibitors; Fluoroquinolones; Horse Diseases; Horses; Injections, Intravenous; Male; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Topoisomerase II Inhibitors | 2006 |
Pharmacokinetics of a single intravenous dose of marbofloxacin in adult donkeys.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Equidae; Female; Fluoroquinolones; Half-Life; Horse Diseases; Horses; Injections, Intravenous; Male; Metabolic Clearance Rate; Quinolones; Species Specificity; Treatment Outcome | 2007 |
Pulmonary function and antimicrobial concentration after marbofloxacin inhalation in horses.
Topics: Administration, Inhalation; Animals; Biological Availability; Bronchoalveolar Lavage Fluid; Cross-Over Studies; Enzyme Inhibitors; Fluoroquinolones; Horse Diseases; Horses; Injections, Intravenous; Quinolones; Random Allocation; Respiratory Function Tests; Time Factors | 2007 |